AwesomeCapital
Search This Blog
Monday, November 25, 2019
Dicerna target hiked to $50 from $35 by Baird
Maintains Outperform
https://www.benzinga.com/stock/DRNA/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.